Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOTEL Max intravenous paracetamol for fever of infectious origin
2014-002588-14Phase 4Completed
- Sponsor
- Universal Pharmaceutical Industries UNIPHARMA
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in fever and bacterial disease comparing APOTEL Max intravenous paracetamol with Placebo (2 arms). Primary endpoint: Achievement of defervescence. Started Aug 2014; status: completed.
02
Drugs
acetaminophen
03
Conditions
feverbacterial disease
Beyond the preview
Go deeper on 2014-002588-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002588-14.